- How many Verio meters are in use today? Worldwide, about
- How many Verio meters are in use today? Worldwide, about 2.5 million, but less popular in the U.S. where the Verio and Verio Flex meters are used.
- I read that the Verio meets the ISO Standard 2013. It also meets the ISO 2015 standard, and would most likely meet the FDA 2014 Guidance standard. Except for a stricter HCT range and criteria, all of the standards are +/- 15%.
- could there be difficulties for an alternative product with the stricter regulations that are in place? Why? Do you buy into the argument that alternative strips are somehow lesser strips?
- How long would it take until the rubber hits the road? Of course, it's all about money. Money to do a once in a product life cycle crash development. And I know the moment I said this about money, the inner trader in you would come out and you would think its a bad idea, like you think GenChoice and GenPrecis are bad ideas. I get that. However, product developments are not usually based on the opinions of stock traders.
- What do you think would be the implications for the negotiations between J&J and Sinocare? Money. J&J probably feels that it has milked these markets for as long as and as hard as they can. Now its time, or even past time, to exit.
- One more question concerning GenSure!: are there legal actions expected concerning the launch of this product? I don't expect any. But perhaps with a little help from people masquerading as DECN shareholders, they could convince J&J to sue, where the suit would be filed primarily to foment more negativity by DECN shareholders surrounding DECN.
J&J's OneTouch Select is an almost identical copy of OneTouch Ultra. J&J said so in their 510K filing. Their clinical trials were run on only 100 patients in what is called an Accuracy Study. DECN owns a patent license to the OneTouch Ultra patents, two of which are expired and one of which was killed. But, people masquerading as DECN shareholders have libeled Mr. Berman into oblivion in public forums. J&J reads these message boards and speaks to the authors of the posts. It might just be worth $350K to bring a suit. A suit would be met with glee over on iHub. What do you think?
3
Decision Diagnostics Corp (DECN) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
A New Federal Contract Partnership Takes Flight If you're watching government tech contracts like a hawk, there's a fresh collaboration to note—Pyramid Systems is hitching up with Bell Federal Systems to deliver AIR-Quire solutions via NASA's Solutions for Enterprise-Wide Procurement VI, known as SEWP VI. With this partnership, these two outfits aim to streamline how...
Continue Reading
Reading Between the Lines of Prosperity You'd think the headlines scream gloom—job insecurity, a shaky economy, ridiculous basic cost hikes. Yet, against the odds like an underdog scrapping past the finish line, the Northwestern Mutual's Personal Prosperity Index crawled up to 71 out of 100, up by a humble three points since mid-year. Unlocking Prosperity in Chaotic...
Continue Reading
Qfin Holdings' Troubled Waters Look, when a stock tanks by nearly 19% overnight, it isn't because of some fluke. And that's precisely what's got Qfin Holdings, Inc. investors gritting their teeth and lawyers sharpening their pencils. Deep Dive into Allegations For those keeping score, we're talking about serious allegations here: between March 18, 2026, and August 25,...
Continue Reading
Firing Up the Holiday Spirit with Cincoro Well, isn't this a timely toast to class? As if the tequila scene wasn't already brimming with options, Cincoro's decided to paint the town gold with a rare addition to its lineup. For those of you who treat your liquor collection like a stockpile of fine art, here's something that'll turn heads this holiday season—the Añejo...
Continue Reading
Forget your usual day at the office, folks; Wednesday on Wall Street was anything but routine. The Dow Jones shot up a dazzling 1,572.58 points, reclaiming vital ground over an important technical threshold like the heavyweight it is. There's more cooking under the hood than mere index moves. We've got stocks jumping the charts like everyone's playing hopscotch, stirring...
Continue Reading
Subtle Winds of Change in Nomad Foods' Financials Ah, Nomad Foods—Europe's frozen food titan, trotting out its third quarter numbers like a well-rehearsed production line. You've got your slight revenue bump of 2.3% on reported streams, hitting €770 million. But dig a little deeper and you find organic revenue doing a waltz at 1.6% year-on-year, surprising no one...
Continue Reading
Breaking Barriers in Energy Storage Innovation Sungrow's latest swift 20-day expedition in the land of renewable energy is a bit of a jaw-dropper. They've whipped up Europe's largest operational Battery Energy Storage System (BESS) at Hams Hall, and they did it at breakneck speed. This ain't just another plug-and-play; it's the 1,243 MWh goliath that's set up to be a key...
Continue Reading
Manulife's Resilience in a Volatile Market Trading has a way of keeping folks on their toes. Just when you think you've ridden the bull long enough, it tries bucking you off. That's how it goes for Manulife Financial Corporation (TSX/NYSE/PSE: MFC), as they reported their Q3 2026 results—marking a seesaw of gains and losses. Core Earnings Shine While Net Income Declines...
Continue Reading
The True Financial Picture of Skilled Trade Programs Ever wonder why that flashy tuition number doesn't line up with your wallet by the end of your training days? That's the reality smashing aspiring lineworkers and future truck drivers in Northern California right in the face. We're talking about a full breakdown here, beyond what the glossy brochures ever tell you....
Continue Reading
IASO Bio’s done it—they've taken a leap into Singapore with their fully human BCMA-targeted CAR-T cell therapy, FUCASO. November 3 was the official launch day, a big moment in Southeast Asia’s healthcare hub. And we're not just talking any therapy. This is a world-first fully human BCMA CAR-T hitting Singapore's market after getting the nod from the Health Sciences...
Continue Reading
Top 5 Most Recently Viewed Articles
Google's Strategic Increase in Capital Expenditure Google's parent company, Alphabet (NASDAQ: GOOGL), has made headlines with its impressive spending on capital expenditures (capex). In its latest earnings report, Google disclosed a staggering $13.1 billion in capex for the third quarter, marking a significant 62% increase from the $8.1 billion spent during the same...
Continue Reading
Zentiva's Initiative Against the Urban Wastewater Treatment Directive Zentiva has recently taken a noteworthy step by filing a legal challenge with the Court of Justice of the European Union. This bold move aims to contest the Urban Wastewater Treatment Directive (UWWTD). The central goal behind this legal action is to protect and ensure access to affordable medicines...
Continue Reading
Alison Phoenix Elevates Role at National Bank of Coxsackie National Bank of Coxsackie is excited to announce the promotion of Alison Phoenix to the position of Athens Branch Manager. This significant advancement in her career reflects her longstanding dedication and contributions to the bank. Experience and Passion for Banking With over 18 years of experience in the...
Continue Reading
BIC's Financial Performance for the First Half of 2025 BIC, a leader in stationery, shavers, and lighters, recently revealed its financial results for the first half of 2025, showcasing both challenges and resilience. In the face of a volatile global environment, BIC recorded net sales of €1,077 million, which reflects a decline of 2.4% at constant currencies compared...
Continue Reading
Rezolve Ai Leading the Charge in AI-Driven Commerce In our fast-evolving digital landscape, the role of AI in reshaping commerce is vast and exciting. Rezolve Ai (NASDAQ: RZLV) is at the forefront of this transformation, offering innovative solutions that promise to enhance business operations and improve customer experiences. Industry forecasts indicate that the AI...
Continue Reading